CSI Market
Sign In | Register

Vertex Pharmaceuticals Inc (VRTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VRTX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Vertex Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent6,143.50
Marketable Securities, Current SH1,708.90
Cash & Short-term Investments7,851.00
Accounts receivable2,134.30
Inventories1,765.10
Prepaid Expense And Other Assets Current791.90
Total Current Assets12,543.70
Goodwill net1,088.00
Intangible Assets412.80
Long-term investments5,799.70
Other Assets, Noncurrent7,579.10
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization1,608.40
Deferred Income Tax Assets Net2,947.80
Operating Lease Right Of Use Asset1,685.10
Total Assets27,423.30
Liabilities
Accounts Payable, Current AC429.50
Accrued Liabilities, Current AC3,179.00
Other Liabilities, Current329.40
Total Current Liabilities3,937.90
Total Long-term Debt0.00
Other liabilities, Noncurrent3,237.50
Finance Lease Liability Noncurrent-
Operating Lease Liability Noncurrent1,986.50
Total Liabilities7,175.40
Stockholders' Equity
Common Stock Value2.50
Additional Paid In Capital Common Stock4,505.70
Retained Earnings / Accumulated Deficit15,691.20
Accumulated Other Comprehensive Income48.50
Other Equity48.50
Common Stockholder's Equity20,247.90
Total Stockholder's Equity20,247.90
Liabilities & Stockholder's Equity27,423.30
4 historic quarters locked

Sign in to unlock the full Vertex Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Vertex Pharmaceuticals Inc Ma Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000875320-26-000259

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.